Journal of the Neurological Sciences
Volume 226, Issue 1 , Pages 59-62 , 15 November 2004

Establishing diagnostic criteria for vascular depression

References 

  1. Soares JC, Mann JJ. The anatomy of mood disorders—review of structural neuroimaging studies. Biol. Psychiatry. 1997;41:86–106
  2. Krishnan KRR, Hays JC, Blazer DG. MRI defined vascular depression. Am. J. Psychiatr. 1997;154:497–501
  3. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M. Clinically defined vascular depression. Am. J. Psychiatr. 1997;154:562–565
  4. Elliott R, Sahakian BJ, McKay AP, Herrod JJ, Robbins TW, Paykel ES. Neuropsychological impairments in unipolar depression: the influence of perceived failure on subsequent performance. Psychol. Med. 1996;26:975–989
  5. Lesser IM, Boone KB, Mehringer CM, Wohl MA, Miller BL, Berman NG. Cognition and white matter hyperintensities in older depressed patients. Am. J. Psychiatr. 1996;153:1280–1287
  6. Steffens DC, Bosworth HB, Provenzale JM, MacFall JR. Subcortical white matter lesions and functional impairment in geriatric depression. Depress. Anxiety. 2002;15:23–28
  7. Simpson S, Baldwin RC, Jackson A, Burns AS. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol. Med. 1998;28(5):1015–1026
  8. Yanai I, Fujikawa T, Horiguchi J, Yamawaki S, Touhouda Y. The 3-year course and outcome of patients with major depression and silent cerebral infarction. J. Affect. Disord. 1998;47(1–3):25–30
  9. Krishnan KRR, Hays JC, George LK, Blazer DG. Six-month outcomes for MRI-related vascular depression. Depress. Anxiety. 1998;8(4):142–146
  10. Salloway S, Correia S, Boyle P, Malloy P, Schneider L, Lavretsky H, et al. MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression. J. Neurol. Sci. 2002;203–204:227–233
  11. Alexopoulos GS, Meyers BS, Young RC, Kalayam B, Kakuma T, Gabrielle M, et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch. Gen. Psychiatry. 2000;57:285–290
  12. Steffens DC, MacFall JR, Payne ME, Welsh-Bohmer KA, Krishnan KRR. Grey-matter lesions and dementia. Lancet. 2000;356:1686–1687
  13. Levy RM, Steffens DC, McQuoid DR, Provenzale JM, MacFall JR, Krishnan KR. MRI lesion severity and mortality in geriatric depression. Am. J. Geriatr. Psychiatry. 2003;11:678–682
  14. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch. Gen. Psychiatry. 2000;57:1071–1076
  15. Steffens DC, Helms MJ, Krishnan KR, Burke GL. Cerebrovascular disease and depression symptoms in the Cardiovascular Health Study. Stroke. 1999;30:2159–2166
  16. Steffens DC, Krishnan KRR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol. Psychiatry. 1998;43:705–712
  17. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. ‘Vascular depression’ hypothesis. Arch. Gen. Psychiatry. 1997;54(10):915–922
  18. Sackett DL, Haynes RB, Guyatt GH. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed.. Boston: Little Brown; 1991;
  19. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR Signal abnormalities at 1.5T in Alzheimer's dementia and normal aging. Am. J. Neuroradiol. 1987;8:421–426
  20. Krishnan KRR, Boyko OB, McDonald WM, Charles HC, MacFall JR, Tupler LA, et al. Magnetic-resonance morphometry: image-analysis methodology development for affective disorder. Depression. 1993;1:159–171
  21. Steffens DC, Hays JC, Krishnan KR. Disability in geriatric depression. Am. J. Geriatr. Psychiatry. 1999;7:34–40
  22. Alexopoulos GS, Kiosses DN, Klimstra S, Kalayam B, Bruce ML. Clinical presentation of the “depression-executive dysfunction syndrome” of late life. Am. J. Geriatr. Psychiatry. 2002;10:98–106
  23. Alexopoulos GS. The depression-executive dysfunction syndrome of late life: a specific target for D3 agonists?. Am. J. Geriatr. Psychiatry. 2001;9:22–29
  24. Simpson SW, Jackson A, Baldwin RC, Burns A. 1997 IPA/Bayer research awards in psychogeriatrics. subcortical hyperintensities in late-life depression: acute response to treatment and neuropsychological impairment. Int. Psychogeriatr. 1997;9(3):257–275
  25. Steffens DC, Krishnan KR, Crump C, Burke GL. Cerebrovascular disease and evolution of depressive symptoms in the Cardiovascular Health Study. Stroke. 2002;33:1636–1644
  26. Steffens DC, Taylor WD, Krishnan KR. Progression of subcortical ischemic disease from vascular depression to vascular dementia. Am. J. Psychiatr. 2003;160:1751–1756
  27. Krishnan KR, Taylor WD, McQuoid DR, MacFall JR, Payne ME, Provenzale JM, et al. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol. Psychiatry. 2004;55:390–397
  28. Reitan RM. Trail Making Test: Manual for Administration and Scoring. Tucson: Reitan Neuropsychological Laboratory; 1992;
  29. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry. 1979;134:382–389
  30. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:55–61

PII: S0022-510X(04)00294-1

doi: 10.1016/j.jns.2004.09.013

Journal of the Neurological Sciences
Volume 226, Issue 1 , Pages 59-62 , 15 November 2004